Nucleophilic functional groups on tissue and plasma macromolecules

Nucleophilic functional groups on tissue and plasma macromolecules refer to electron-rich chemical moieties, such as sulfhydryl (-SH), amino (-NH2), and hydroxyl (-OH) groups, found on proteins and other biological polymers (DrugBank). These groups are primary sites for covalent modification by electrophilic drugs or their reactive metabolites through processes like alkylation, acylation, or arylation (PubMed: 11738516). In clinical oncology, this interaction is exploited by alkylating agents such as cyclophosphamide and busulfan to disrupt cellular processes and inhibit tumor growth (PubMed: 15922018). However, non-specific covalent binding to these sites is also a major cause of drug-induced toxicity and the formation of haptens (PubMed: 12490370). Haptens can trigger immune-mediated hypersensitivity reactions, which are a significant concern in drug development and safety (PubMed: 10792304). Consequently, these nucleophilic sites are critical for understanding both the therapeutic mechanisms and the adverse effect profiles of many reactive therapeutic agents.

Other names

Nucleophilic sitesProtein nucleophilesTissue nucleophilesMacromolecular nucleophilesCovalent binding sites

Covalent modification (specifically alkylation) of nucleophilic centers on proteins and other macromolecules (DrugBank).